Should I Buy Titan Medical Stock Guide

Deciding whether to buy stock in requires looking at a company that has undergone massive structural changes over the last few years. As of early 2026, the short answer is that the original "Titan Medical" (TMDI) essentially no longer exists as an independent surgical robotics company following a reverse take-over and a delisting from major exchanges . 1. The Core Business Has Shifted

The original Titan Medical focused on the . However, after struggling with funding and failing to find a buyer, the company halted development of that robot in 2023. By late 2024, Titan Medical entered into a reverse take-over (RTO) agreement with Conavi Medical Inc. . should i buy titan medical stock

The company is now a "micro-cap" stock, valued at roughly $33 million to $40 million , which makes it extremely sensitive to small pieces of news. Summary Checklist: Should You Buy? Consideration Risk Tolerance Deciding whether to buy stock in requires looking

If you wanted , this is no longer the right play. If you like Cardiovascular Imaging , the new Conavi entity might interest you. Market Status The Core Business Has Shifted The original Titan

Buying on the OTC market (TMDIF) or TSX Venture (CNVI) carries more technical risk and higher fees with some brokers.

If you find a ticker symbol for Titan Medical today, it is likely trading on the TSX Venture Exchange (under the new Conavi identity) or on the OTC (Over-The-Counter) markets under the ticker TMDIF . OTC stocks often have low "liquidity," meaning it can be hard to buy or sell large amounts of shares without moving the price significantly. 3. Financial Performance

The "Titan" you see today is likely the "Resulting Issuer" known as Conavi Medical Corp (CNVI.V), which focuses on image-guided technologies for minimally invasive heart procedures rather than surgical robotics. 2. Listing Status and Liquidity